Macular Degeneration, Dry
5
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Algorithm Prediction
Research Leaders
11 sponsors active, led by Ospedale San Raffaele
Related Conditions
Often studied with 10 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
Observation of the Natural Course of Age-related Macular Degeneration
Prediction of Progression of Age-Related Macular Degeneration
Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration
Research Network
Common Treatments
- Algorithm Prediction1
- Pascal Synthesis 577 Sham Topcon Corporation Tokyo Japan1
- White Light Stimulation1
- Pascal Synthesis 577 Subthreshold Laser Topcon Corporation Tokyo Japan1
- Retimax Vision Trainer1
Active Sponsors
- Ospedale San Raffaele1
- Illinois Retina Associates1
- University of Rome Tor Vergata1
- Stanford University1
- University of Genova1
Top Investigators
University of Illinois at Chicago
Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa -UNIMORE- University of Modena and Reggio Emilia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Department of Clinical Pharmacology, Medical University of Vienna
Related Conditions
- Macular Degeneration Senile2
- Dry Agerelated Macular Degeneration1
- Macular Degeneration1
- Macular Degeneration Advanced1
- Macular Degeneration Nonexudative1